Steve Warrington

4.3k total citations
106 papers, 2.6k citations indexed

About

Steve Warrington is a scholar working on Surgery, Pharmacology and Physiology. According to data from OpenAlex, Steve Warrington has authored 106 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 17 papers in Pharmacology and 17 papers in Physiology. Recurrent topics in Steve Warrington's work include Helicobacter pylori-related gastroenterology studies (11 papers), Gastroesophageal reflux and treatments (10 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Steve Warrington is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (11 papers), Gastroesophageal reflux and treatments (10 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Steve Warrington collaborates with scholars based in United Kingdom, United States and Japan. Steve Warrington's co-authors include Malcolm Boyce, Kathy Baisley, Yoichiro Ogama, Mark G. Hibberd, Helen Jenkins, Hiroyuki Okamoto, Yuichi Sakurai, Richard O. Jenkins, Kiyoshi Ashida and Akira Nishimura and has published in prestigious journals such as The Lancet, Gastroenterology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Steve Warrington

105 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Warrington United Kingdom 29 537 496 342 330 324 106 2.6k
M. J. Kendall United Kingdom 29 362 0.7× 452 0.9× 158 0.5× 349 1.1× 380 1.2× 135 3.1k
Zvi Ackerman Israel 30 644 1.2× 405 0.8× 206 0.6× 168 0.5× 561 1.7× 106 3.2k
Siva G. Somasundaram Russia 26 547 1.0× 256 0.5× 142 0.4× 194 0.6× 907 2.8× 84 2.8k
Norton J. Greenberger United States 30 950 1.8× 361 0.7× 256 0.7× 254 0.8× 358 1.1× 86 3.0k
Marco Tuccori Italy 31 394 0.7× 136 0.3× 202 0.6× 124 0.4× 485 1.5× 110 2.7k
Richard J. Kitz Germany 23 694 1.3× 368 0.7× 153 0.4× 446 1.4× 1.1k 3.5× 78 3.6k
David H. Lawson United Kingdom 28 565 1.1× 396 0.8× 231 0.7× 843 2.6× 400 1.2× 74 3.8k
Matteo Neri Italy 28 937 1.7× 250 0.5× 705 2.1× 340 1.0× 241 0.7× 101 2.2k
Roy Sherwood United Kingdom 41 1.2k 2.2× 666 1.3× 309 0.9× 459 1.4× 1.2k 3.6× 198 5.6k
Walter K. Kraft United States 29 323 0.6× 329 0.7× 70 0.2× 243 0.7× 213 0.7× 128 2.5k

Countries citing papers authored by Steve Warrington

Since Specialization
Citations

This map shows the geographic impact of Steve Warrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Warrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Warrington more than expected).

Fields of papers citing papers by Steve Warrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Warrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Warrington. The network helps show where Steve Warrington may publish in the future.

Co-authorship network of co-authors of Steve Warrington

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Warrington. A scholar is included among the top collaborators of Steve Warrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Warrington. Steve Warrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyce, Malcolm, et al.. (2016). Randomised trial of the effect of a gastrin/CCK2 receptor antagonist on esomeprazole-induced hypergastrinaemia: evidence against rebound hyperacidity. European Journal of Clinical Pharmacology. 73(2). 129–139. 5 indexed citations
2.
Norris, Virginia, Steve Warrington, & Malcolm Boyce. (2015). Effect of Inhaled Interferon Beta-1a on Carbon Monoxide Transfer Factor in Healthy Volunteers. Journal of Interferon & Cytokine Research. 36(2). 113–119. 1 indexed citations
3.
Kim, John, Malcolm Boyce, Steve Warrington, et al.. (2015). Pharmacokinetics, pharmacodynamics and food effect of LB30870, a novel direct thrombin inhibitor, after single oral doses in healthy men. Xenobiotica. 45(8). 663–671. 1 indexed citations
4.
Francis, James N., Campbell Bunce, Claire Horlock, et al.. (2014). A novel peptide-based pan-influenza A vaccine: A double blind, randomised clinical trial of immunogenicity and safety. Vaccine. 33(2). 396–402. 46 indexed citations
5.
6.
McCord, Gary, et al.. (2011). Incidence of Staphylococcus aureus Nasal Colonization and Soft Tissue Infection Among High School Football Players. The Journal of the American Board of Family Medicine. 24(4). 429–435. 17 indexed citations
7.
Waldmeier, Felix, Gerard Bruin, Ulrike Glaenzel, et al.. (2010). Pharmacokinetics, Metabolism, and Disposition of Deferasirox in β-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State. Drug Metabolism and Disposition. 38(5). 808–816. 76 indexed citations
8.
9.
Norris, Virginia, Kathy Baisley, Kate M. Dunn, Steve Warrington, & Anna Morocutti. (2007). Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24‐h intragastric pH in healthy volunteers. Alimentary Pharmacology & Therapeutics. 25(4). 501–510. 21 indexed citations
10.
Comer, Mary B., et al.. (2005). Pharmacokinetics and pharmacodynamics of BB‐10153 , a thrombin‐activatable plasminogen, in healthy volunteers. Journal of Thrombosis and Haemostasis. 3(6). 1180–1186. 7 indexed citations
11.
Ravic, M., Steve Warrington, Malcolm Boyce, Kate M. Dunn, & A. E. Johnston. (2004). Repeated dosing with donepezil does not affect the safety, tolerability or pharmacokinetics of single‐dose thioridazine in young volunteers. British Journal of Clinical Pharmacology. 58(s1). 34–40. 6 indexed citations
12.
Carey, Wayne, Steve Warrington, William Kerns, et al.. (2004). Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men. International Journal of Clinical Pharmacology and Therapeutics. 42(10). 534–542. 55 indexed citations
13.
Boyce, Malcolm, Kate M. Dunn, & Steve Warrington. (2001). Hemodynamic and Electrocardiographic Effects of Almotriptan in Healthy Volunteers. Journal of Cardiovascular Pharmacology. 37(3). 280–289. 18 indexed citations
14.
15.
Vogelmeier, Claus, et al.. (1997). The Intrapulmonary Half-Life and Safety of Aerosolized Alpha1-Protease Inhibitor in Normal Volunteers. American Journal of Respiratory and Critical Care Medicine. 155(2). 536–541. 33 indexed citations
16.
Davies, N. T. & Steve Warrington. (1986). The phytic acid mineral, trace element, protein and moisture content of UK Asian immigrant foods.. Scientiae mathematicae Japonicae. 40(1). 49–59. 42 indexed citations
17.
Warrington, Steve, S. I. Ankier, & Paul Turner. (1986). Evaluation of Possible Interactions between Ethanol and Trazodone or Amitriptyline. Neuropsychobiology. 15(1). 31–37. 8 indexed citations
18.
19.
Stephens, W P, et al.. (1983). Vitamin D state of Asians living in Pakistan.. BMJ. 286(6360). 182–184. 32 indexed citations
20.
Warrington, Steve, et al.. (1983). Propranolol concentrations in plasma after insertion into the vagina.. BMJ. 287(6401). 1247–1248. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. J. Kendall Breakdown of academic impact, for papers by Zvi Ackerman Breakdown of academic impact, for papers by Siva G. Somasundaram Breakdown of academic impact, for papers by Norton J. Greenberger Breakdown of academic impact, for papers by Marco Tuccori Breakdown of academic impact, for papers by Richard J. Kitz Breakdown of academic impact, for papers by David H. Lawson Breakdown of academic impact, for papers by Matteo Neri Breakdown of academic impact, for papers by Roy Sherwood Breakdown of academic impact, for papers by Walter K. Kraft
Rankless by CCL
2026